The societal cost of treatment-seeking patients with borderline personality disorder in Germany

被引:19
|
作者
Wagner, Till [1 ]
Assmann, Nele [1 ]
Koehne, Sandra [1 ]
Schaich, Anja [1 ,5 ]
Alvarez-Fischer, Daniel [2 ,3 ]
Borgwardt, Stefan [1 ]
Arntz, Arnoud [4 ]
Schweiger, Ulrich [1 ]
Fassbinder, Eva [1 ,5 ]
机构
[1] Univ Lubeck, Dept Psychiat & Psychotherapy, Ratzeburger Allee 160, D-23538 Lubeck, Germany
[2] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
[3] Univ Lubeck, Inst Syst Motor Sci, Lubeck, Germany
[4] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands
[5] Christian Albrechts Univ Kiel, Dept Psychiat & Psychotherapy, Kiel, Germany
关键词
Borderline personality disorder; Health economics; Cost-of-illness; Psychiatric care; STANDARDIZED UNIT COSTS; ECONOMIC-EVALUATION; 10-YEAR COURSE; COMORBIDITY; SEVERITY; OUTCOMES; ILLNESS; MOOD; LIFE;
D O I
10.1007/s00406-021-01332-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
According to previous research, borderline personality disorder (BPD) is associated with high cost-of-illness. However, there is still a shortage of cost-of-illness-studies assessing costs from a broad societal perspective, including direct and indirect costs. Further, there are considerable differences in the results among the existing studies. In the present study, 167 German men and women seeking specialized outpatient treatment for BPD were included. We assessed societal cost-of-illness bottom-up through structured face-to-face interviews and encompassed a wide range of cost components. All costs were calculated for the 2015 price level. Cost-of-illness amounted to euro 31,130 per patient and year preceding disorder-specific outpatient treatment. euro 17,044 (54.8%) were direct costs that were mostly related to hospital treatment. Indirect costs amounted to euro 14,086 (45.2%). Within indirect costs, costs related to work disability were the most crucial cost driver. The present study underlines the tremendous economic burden of BPD. According to the present study, both the direct and indirect costs are of significant importance for the societal costs associated with BPD. Besides the need for more disorder-specific treatment facilities for men and women with BPD, we assume that education and employment are topics that should be specifically targeted and individually supported at an early stage of treatment. Trial Registration: German Clinical Trial Registration, DRKS00011534, Date of Registration: 11/01/2017, retrospectively registered.
引用
收藏
页码:741 / 752
页数:12
相关论文
共 50 条
  • [41] Cost of borderline personality disorder in Catalonia (Spain)
    Salvador-Carulla, L.
    Bendeck, M.
    Ferrer, M.
    Andion, O.
    Aragones, E.
    Casas, M.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29 (08) : 490 - 497
  • [42] Treatment Attitude and Therapy Outcome in Patients With Borderline Personality Disorder
    Wenzel, Amy
    Jeglic, Elizabeth
    Levy-Mack, Hollie
    Beck, Aaron
    Brown, Gregory
    [J]. JOURNAL OF COGNITIVE PSYCHOTHERAPY, 2008, 22 (03) : 250 - 257
  • [43] Psychotherapists' Attitudes Towards the Treatment of Patients with Borderline Personality Disorder
    Jobst, Andrea
    Hoerz, Susanne
    Birkhofer, Andreas
    Martius, Philipp
    Rentrop, Michael
    [J]. PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2010, 60 (3-4) : 126 - 131
  • [44] THE TREATMENT OF BORDERLINE PERSONALITY DISORDER PATIENTS WITH CURRENT SUICIDAL BEHAVIOUR
    Barbe, Remy P.
    Rubovszky, Gregoire
    Venturini-Andreoli, Aurora
    Andreoli, Antonio
    [J]. CLINICAL NEUROPSYCHIATRY, 2005, 2 (05): : 283 - 291
  • [45] Practice guideline for the treatment of patients with borderline personality disorder - Introduction
    不详
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (10): : 2 - 2
  • [46] Demonstrating Adherence to Guidelines for the Treatment of Patients With Borderline Personality Disorder
    Kolla, Nathan J.
    Links, Paul S.
    MeMain, Shelley
    Streiner, David L.
    Cardish, Robert
    Cook, Michele
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2009, 54 (03): : 181 - 189
  • [47] THE ROLE OF PHARMACOTHERAPY IN THE TREATMENT OF PATIENTS WITH BORDERLINE PERSONALITY-DISORDER
    STONE, MH
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1989, 25 (04) : 564 - 571
  • [48] Psychopathology and treatment of borderline personality disorder
    Bohus, M.
    Schmahl, C.
    [J]. NERVENARZT, 2007, 78 (09): : 1069 - 1080
  • [49] Integrated treatment for borderline personality disorder
    Oldham, John M.
    [J]. PSYCHIATRIC ANNALS, 2006, 36 (05) : 361 - +
  • [50] Treatment Advances in Borderline Personality Disorder
    Nelson, Katharine J.
    Schulz, S. Charles
    [J]. PSYCHIATRIC ANNALS, 2012, 42 (02) : 59 - 64